Embecta

EMBCNasdaq United States Health Care Medical/Dental Instruments

Market cap

$316.727 M

$5.59 +5.47%

Close of 22 Sept 2026

Revenue

$1.08B

#1486 by revenue

Earnings

$95.4M

#1332 by earnings

Shares outstanding

56,659,599

Latest filing cover page

P/E ratio

3.3

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →

#58AVITA MedicalRCEL$355.3M
#59Mobia MedicalMOBI$318.3M
#60EmbectaEMBC$316.7M
#61Treace Medical ConceptsTMCI$298.5M
#62Anika TherapeuticsANIK$279.6M

Insiders buying

All insider buying →

4 open-market purchases by officers and directors of Embecta, worth $557.9K. Grants and option exercises are excluded.

Robert J. Hombach$223.8K
45,000 shares at $4.97 on 12 Aug 2026 · filed 13 Aug 2026
Devdatt KurdikarPresident and CEO$140.9K
30,000 shares at $4.70 on 12 Aug 2026 · filed 13 Aug 2026
Jeffrey Z. MannPres, Pharm Svc&Prod Mgmt, CLO$99.8K
20,000 shares at $4.99 on 12 Aug 2026 · filed 13 Aug 2026
Jacob ElguiczeSVP and CFO$93.4K
20,000 shares at $4.67 on 12 Aug 2026 · filed 13 Aug 2026

What if Embecta were worth as much as…

Open the what-if tool →

Gold $30.2T

$533,607.20

Per share 95,457× higher

Bitcoin $1.74T

$30,738.92

Per share 5,499× higher

Nvidia $5.52T

$97,349.21

Per share 17,415× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Embecta are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.